EXOZ (eXoZymes Inc. Common Stock) Stock Analysis - Financials

eXoZymes Inc. Common Stock (EXOZ) is a publicly traded Healthcare sector company. As of May 21, 2026, EXOZ trades at $9.40 with a market cap of $80.97M and a P/E ratio of -8.83. EXOZ moved -2.11% today. Year to date, EXOZ is -15.50%; over the trailing twelve months it is -10.22%. Its 52-week range spans $7.08 to $23.99. Rallies surfaces EXOZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are EXOZ's key financials?

EXOZ financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EXOZ recently traded at $9.40. Market cap is $80.97M. P/E ratio is -8.83. Revenue is $0.

EXOZ Key Metrics

Key financial metrics for EXOZ
MetricValue
Price$9.40
Market Cap$80.97M
P/E Ratio-8.83
EPS$-1.09
Dividend Yield0.00%
52-Week High$23.99
52-Week Low$7.08
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$-9.16M
Gross Margin0.00%

EXOZ Annual Financials

YearRevenueNet IncomeEPS
2025$0$-9.16M$-1.09

Latest EXOZ News

Recent EXOZ Insider Trades

  • Korman Tyler Paz sold 750 (~$7.89K) on Apr 9, 2026.
  • Korman Tyler Paz sold 750 (~$7.53K) on Apr 8, 2026.
  • Heltzen Michael bought 1.04K (~$10.63K) on Jul 2, 2025.

EXOZ Analyst Consensus

EXOZ analyst coverage data. Average price target: $0.00.

Common questions about EXOZ

What are EXOZ's key financials?
EXOZ financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. EXOZ recently traded at $9.40. Market cap is $80.97M. P/E ratio is -8.83. Revenue is $0.
Is EXOZ research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EXOZ. It does not provide personalized investment advice.
EXOZ

EXOZ